Pioneering precision medicine for colorectal cancer

Credit: Cancer Biology & Medicine (2023). DOI: 10.20892/j.issn.2095-3941.2023.0293 A new perspective paper explores the current state and future directions of precision medicine in colorectal cancer (CRC). It outlines advancements in molecular testing and their implications for targeted and immunological therapies in CRC. This research is significant because it suggests pathways to more personalized treatment, potentially leading to higher survival rates and an improved quality of life for CRC patients. Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally. While surgery with adjuvant chemotherapy remains the standard treatment, Read More